Back to Browse Journals » International Journal of Nanomedicine » Volume 1 » Issue 4

Megestrol acetate in cachexia and anorexia

Authors Shing-Shing Yeh, Michael W Schuster

Published Date February 2006 Volume 2006:1(4) Pages 411—416

DOI http://dx.doi.org/

Published 23 February 2006

Shing-Shing Yeh1, Michael W Schuster2

1Northport vAMC, Geriatric division, Northport, NY 11768; 2Weill Medical College of Cornell University and the New York Presbyterian Hospital, New York, NY 10021, USA

Abstract: The aim is to review major clinical trials that have used megestrol acetate (MA) in the treatment of cachexia across several disease states. A review of general usage and potential side-effects are discussed. A theory that the newly approved nanocrystal formation of MA can better deliver this potent medication for treatment will also be reviewed.

Keywords: megestrol acetate, nanocrystalline particles, cachexia

Download Article [PDF] 

Readers of this article also read:

Spatial memory impairments in amnestic mild cognitive impairment in a virtual radial arm maze

Lee JY, Kho S, Yoo HB, Park S, Choi JS, Kwon JS, Cha KR, Jung HY

Neuropsychiatric Disease and Treatment 2014, 10:653-660

Published Date: 17 April 2014

Enhancing the bioactivity of Poly(lactic-co-glycolic acid) scaffold with a nano-hydroxyapatite coating for the treatment of segmental bone defect in a rabbit model

Wang DX, He Y, Bi L, Qu ZH, Zou JW, Pan Z, Fan JJ, Chen L, Dong X, Liu XN, Pei GX, Ding JD

International Journal of Nanomedicine 2013, 8:1855-1865

Published Date: 9 May 2013

Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy

Enriquez GG, Rizvi SAA, D’Souza MJ, Do DP

International Journal of Nanomedicine 2013, 8:1393-1402

Published Date: 10 April 2013

Different corrosive effects on hydroxyapatite nanocrystals and amine fluoride-based mouthwashes on dental titanium brackets: a comparative in vitro study

Lelli M, Marchisio O, Foltran I, Genovesi A, Montebugnoli G, Marcaccio M, Covani U, Roveri N

International Journal of Nanomedicine 2013, 8:307-314

Published Date: 17 January 2013

Development of a nanoporous and multilayer drug-delivery platform for medical implants

Karagkiozaki V, Vavoulidis E, Karagiannidis PG, Gioti M, Fatouros DG, Vizirianakis IS, Logothetidis S

International Journal of Nanomedicine 2012, 7:5327-5338

Published Date: 8 October 2012

Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles

Deng WW, Cao X, Wang M, Qu R, Su WY, Yang Y, Wei YW, Xu XM, Yu JN

International Journal of Nanomedicine 2012, 7:1297-1311

Published Date: 14 March 2012

Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma

Ashish Udhrain, Keith M Skubitz, Donald W Northfelt

International Journal of Nanomedicine 2007, 2:345-352

Published Date: 10 October 2007

Mood fluctuations in Parkinson’s disease: a pilot study comparing the effects of intravenous and oral levodopa administration

Irene Hegeman Richard, Samuel Frank, Kori A LaDonna, Hongkun Wang, Michael P McDermott, Roger Kurlan

Neuropsychiatric Disease and Treatment 2005, 1:261-268

Published Date: 18 February 2005